139 related articles for article (PubMed ID: 37407446)
1. Cancer-specific apoptosis induction in canine lymphoma cell lines by the endocytosis inhibitor dynasore.
Suemura M; Miyata H; Kawamura R; Takahashi S; Igase M; Mizuno T; Ohama T; Shibutani S; Iwata H
J Vet Med Sci; 2023 Aug; 85(8):820-827. PubMed ID: 37407446
[TBL] [Abstract][Full Text] [Related]
2. Benzyl Isothiocyanate, a Vegetable-Derived Compound, Induces Apoptosis via ROS Accumulation and DNA Damage in Canine Lymphoma and Leukemia Cells.
Henklewska M; Pawlak A; Li RF; Yi J; Zbyryt I; Obmińska-Mrukowicz B
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769202
[TBL] [Abstract][Full Text] [Related]
3. The endocytosis inhibitor dynasore induces a DNA damage response pathway that can be manipulated for enhanced apoptosis.
Suemura M; Shibutani S; Iwata H
Biochem Biophys Res Commun; 2023 Feb; 645():1-9. PubMed ID: 36657293
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate induces high level of apoptosis in canine lymphoma/leukemia cell lines.
Pawlak A; Kutkowska J; Obmińska-Mrukowicz B; Rapak A
Res Vet Sci; 2017 Oct; 114():518-523. PubMed ID: 28992489
[TBL] [Abstract][Full Text] [Related]
5. Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model.
Umeki S; Ema Y; Suzuki R; Kubo M; Hayashi T; Okamura Y; Yamazaki J; Tsujimoto H; Tani K; Hiraoka H; Okuda M; Mizuno T
J Vet Med Sci; 2013 May; 75(4):467-74. PubMed ID: 23196801
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.
Nadeau MÈ; Rico C; Tsoi M; Vivancos M; Filimon S; Paquet M; Boerboom D
BMC Cancer; 2015 Jun; 15():479. PubMed ID: 26104798
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Xanthohumol Derivatives on Apoptosis Induction in Canine Lymphoma and Leukemia Cell Lines.
Grudzień M; Pawlak A; Tronina T; Kutkowska J; Kruszyńska A; Popłoński J; Huszcza E; Rapak A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511484
[TBL] [Abstract][Full Text] [Related]
9. The effect of common antineoplastic agents on induction of apoptosis in canine lymphoma and leukemia cell lines.
Pawlak A; Rapak A; Zbyryt I; Obmińska-Mrukowicz B
In Vivo; 2014; 28(5):843-50. PubMed ID: 25189898
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jan; 199(1):103-9. PubMed ID: 24332606
[TBL] [Abstract][Full Text] [Related]
11. Decreased sensitivity of cyclin-dependent kinase 4/6 inhibitors, palbociclib and abemaciclib to canine lymphoma cells with high p16 protein expression and low retinoblastoma protein phosphorylation.
Maylina L; Kambayashi S; Baba K; Igase M; Mizuno T; Okuda M
J Vet Med Sci; 2023 Jan; 85(1):99-104. PubMed ID: 36450591
[TBL] [Abstract][Full Text] [Related]
12. Flavopiridol Strongly Sensitizes Canine Lymphoma Cells to TRAIL-induced Apoptosis.
Pawlak A; DE Miguel D; Kutkowska J; Obmińska-Mrukowicz B; Rapak A; Martinez-Lostao L
Anticancer Res; 2017 Dec; 37(12):6655-6665. PubMed ID: 29187441
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of a first-generation valosin-containing protein inhibitor (CB-5083) against canine lymphoma.
Gareau A; Rico C; Boerboom D; Nadeau ME
Vet Comp Oncol; 2018 Sep; 16(3):311-317. PubMed ID: 29314493
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p16 tumor suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells.
Fujiwara-Igarashi A; Goto-Koshino Y; Mochizuki H; Sato M; Fujino Y; Ohno K; Tsujimoto H
Res Vet Sci; 2014 Aug; 97(1):60-3. PubMed ID: 24815345
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of perphenazine on canine lymphoma.
Tsuji S; Yabe R; Usui T; Mizuno T; Ohama T; Sato K
J Vet Med Sci; 2016 Sep; 78(8):1293-8. PubMed ID: 27150024
[TBL] [Abstract][Full Text] [Related]
16. Olsalazine inhibits cell proliferation and DNA methylation in canine lymphoid tumor cell lines.
Itoh S; Yamazaki J; Iwahana M; Tsukamoto A
Pol J Vet Sci; 2021 Dec; 24(4):515-523. PubMed ID: 35179837
[TBL] [Abstract][Full Text] [Related]
17. Antitumour effect and modulation of expression of the ABCB1 gene by perifosine in canine lymphoid tumour cell lines.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jul; 201(1):83-90. PubMed ID: 24881508
[TBL] [Abstract][Full Text] [Related]
18. Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.
Taher L; Beck J; Liu W; Roolf C; Soller JT; Rütgen BC; Hammer SE; Chodisetti M; Sender S; Sterenczak KA; Fuellen G; Junghanss C; Brenig B; Nolte I; Schütz E; Murua Escobar H
Sci Rep; 2018 Apr; 8(1):6279. PubMed ID: 29674676
[TBL] [Abstract][Full Text] [Related]
19. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment.
Mizuno T; Kato Y; Kaneko MK; Sakai Y; Shiga T; Kato M; Tsukui T; Takemoto H; Tokimasa A; Baba K; Nemoto Y; Sakai O; Igase M
Sci Rep; 2020 Jul; 10(1):11476. PubMed ID: 32651429
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of IRAK-4 inhibitors against canine lymphoid malignancies.
Park JH; Lee JH; An JH; Park CW; Choi YP; Seo SW; Lee HW; Youn HY
Vet Comp Oncol; 2022 Sep; 20(3):632-640. PubMed ID: 35340094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
